Metabolon, a provider of metabolomics solutions for precision medicine applications, announced the launch of its new Biological Stress Discovery Panel.

Part of the Metabolon Discover portfolio of metabolomics services, the Biological Stress Discovery Panel encompasses 114 metabolites strongly associated with chronic stress and provides insights into various biological stress pathways, including inflammation, injury, circulation, and oxidative stress. The panel also examines other signaling molecules and signatures that can determine an individual’s capacity to address stress and identify the presence and activity of specific stressors. 

The Biological Stress Discovery Panel incorporates new visualization tools and allows researchers to compare results across different data sets to identify statistically significant changes in metabolite abundance. Researchers also have access to detailed associations between metabolites and biological pathways that can help uncover biological significance.

Further reading: Metabolon Launches Targeted Panels to Help Identify Gut Health Biomarkers

“Metabolon is at the forefront of research, enabling a better understanding of disease mechanisms,” says Annie Evans, senior director of Research and Development at Metabolon.  “Our new Biological Stress Discovery Panel provides an in-depth understanding of the specific biological stressors impacting individuals, thereby enabling the development of tailored solutions to address unique needs and overcome disease management challenges.”

Prolonged periods of stress in the human body contribute to the development of numerous diseases. Stressors result from internal and external factors such as injuries, toxic substances, infections, and the necessary disturbances caused by food intake and metabolism, negatively impacting human well-being. Intricate coordination between the circulatory, endocrine, nervous, and immune systems allows the body to mount an appropriate response to these stressors, but this complex system is poorly understood.